Caris Life Sciences to Attend Q4 2025 Investor Conferences

IRVING, Texas, Nov. 17, 2025 /PRNewswire/ — Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that the company will attend the following investor conferences:

  • Wolfe Research’s 7th Annual Healthcare Conference: New York City, New York
    • Investor meetings: November 18
  • Citi’s 2025 Global Healthcare Conference: Miami, Florida
    • Investor meetings: December 3
  • 8th Annual Evercore Healthcare Conference: Miami, Florida
    • Investor meetings: December 4

Contact IR@CarisLS.com to schedule meetings.


About Caris Life Sciences

Caris Life Sciences® (Caris) is a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer that is actively developing and commercializing innovative solutions to transform healthcare. Through comprehensive molecular profiling (Whole Exome and Whole Transcriptome Sequencing) and the application of advanced AI and machine learning algorithms at scale, Caris has created the large-scale, multimodal clinico-genomic database and computing capability needed to analyze and further unravel the molecular complexity of disease. This convergence of next-generation sequencing, AI and machine learning technologies, and high-performance computing provides a differentiated platform to develop the latest generation of advanced precision medicine diagnostic solutions for early detection, diagnosis, monitoring, therapy selection and drug development. 

Caris was founded with a vision to realize the potential of precision medicine in order to improve the human condition.  Headquartered in Irving, Texas, Caris has offices in Phoenix, New York, Cambridge (MA), Tokyo, Japan and Basel, Switzerland. Caris or its distributor partners provide services in the U.S. and other international markets. 

Caris Life Sciences Media:  
Corporate Communications
CorpComm@CarisLS.com
214.294.5606 

Investor Relations:

IR@CarisLS.com

917.689.3511

View original content to download multimedia:https://www.prnewswire.com/news-releases/caris-life-sciences-to-attend-q4-2025-investor-conferences-302616558.html

SOURCE Caris Life Sciences

Staff

Recent Posts

EDETEK Launches “Ensemble” AI Managed Services to Simplify Adoption of AI and Accelerate Clinical Development

Orchestrated AI delivered as a service for measurable impactPRINCETON, N.J., Jan. 14, 2026 /PRNewswire/ -- EDETEK…

9 hours ago

MediCapture Launches aiScope™ Pilot for Veterinary Sciences at VMX 2026

Medical AI Made Easy—From Lab to Real-World Training & Practical Use CHEROKEE, Texas, Jan. 14,…

9 hours ago

Amsive Announces Amsive Health, Formalizing Its Healthcare Marketing Practice to Drive Accelerated Growth for Health Plans, Health Systems, and Providers

Built on decades of healthcare experience, trusted by the nation's leading brands, and powered by…

9 hours ago

Therap Services Sponsored the Arc and NASDDDS in 2025, Supporting Innovation in Human Services

TORRINGTON, Conn., Jan. 14, 2026 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…

9 hours ago

Event Modules’ MobileOp4 Triage Unit Selected by AMR as Primary Medical Operations Platform for the 2026 Fiesta Bowl & College Playoff Football Semifinal

NASHVILLE, Tenn., Jan. 14, 2026 /PRNewswire/ -- Event Modules, the rental and deployment arm supporting…

9 hours ago

Own the Bone® and RevelAi Health Partner to Launch AI-Powered Bone Health Navigator Aligned with CMS’ TEAM Model

Collaboration will give fracture liaison services an AI "navigator" to operationalize post-fracture bone health and…

9 hours ago